• 12.09.2017

On September 12, representatives from the pharmaceutical companies within AmCham Healthcare Committee met with the Medicines and Medical Devices Agency in a technical meeting on new pharmacovigilance regulations. In particular, the discussions focused on the mechanisms, deadlines and categories of reporting, including via electronic means, related to safety and adverse reactions of drugs. The question-and-answer section of the event was protocolled and will be shared with those who were unable to attend.